ASH 2022: Lymphoma

• 

  CAR-Hematotox Score Predicts Toxicity, Infection & Clinical Outcomes in MCL

  Dec 19, 2022

• 

  Metabolic Tumor Volume Predicts Response to Loncastuximab Tesirine in DLBCL

  Dec 16, 2022

• 

  Odronextamab Scores in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  Dec 15, 2022

• 

  High-Dose Chemotherapy Plus ASCT Superior to Standard Immune-Chemotherapy in Primary CNS Lymphoma

  Dec 15, 2022